BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31971829)

  • 1. Dosimetric impact of organ at risk daily variation during prostate stereotactic ablative radiotherapy.
    Devlin L; Dodds D; Sadozye A; McLoone P; MacLeod N; Lamb C; Currie S; Thomson S; Duffton A
    Br J Radiol; 2020 Apr; 93(1108):20190789. PubMed ID: 31971829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment planning comparison of IMPT, VMAT and 4π radiotherapy for prostate cases.
    Tran A; Zhang J; Woods K; Yu V; Nguyen D; Gustafson G; Rosen L; Sheng K
    Radiat Oncol; 2017 Jan; 12(1):10. PubMed ID: 28077128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved distance-to-dose correlation for predicting bladder and rectum dose-volumes in knowledge-based VMAT planning for prostate cancer.
    Wall PDH; Carver RL; Fontenot JD
    Phys Med Biol; 2018 Jan; 63(1):015035. PubMed ID: 29131812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
    Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
    Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate stereotactic ablative radiation therapy using volumetric modulated arc therapy to dominant intraprostatic lesions.
    Murray LJ; Lilley J; Thompson CM; Cosgrove V; Mason J; Sykes J; Franks K; Sebag-Montefiore D; Henry AM
    Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):406-15. PubMed ID: 24685447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between volume changes and spatial dose metrics for the urinary bladder during local versus pelvic irradiation for prostate cancer.
    Casares-Magaz O; Moiseenko V; Hopper A; Pettersson NJ; Thor M; Knopp R; Deasy JO; Muren LP; Einck J
    Acta Oncol; 2017 Jun; 56(6):884-890. PubMed ID: 28401808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of VMAT-SABR treatment plans with flattening filter (FF) and flattening filter-free (FFF) beam for localized prostate cancer.
    Chung JB; Kim JS; Eom KY; Kim IA; Kang SW; Lee JW; Kim JY; Suh TS
    J Appl Clin Med Phys; 2015 Nov; 16(6):302–313. PubMed ID: 26699585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strict bladder filling and rectal emptying during prostate SBRT: Does it make a dosimetric or clinical difference?
    Byun DJ; Gorovets DJ; Jacobs LM; Happersett L; Zhang P; Pei X; Burleson S; Zhang Z; Hunt M; McBride S; Kollmeier MA; Zelefsky MJ
    Radiat Oncol; 2020 Oct; 15(1):239. PubMed ID: 33066781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A treatment planning study comparing IMRT techniques and cyber knife for stereotactic body radiotherapy of low-risk prostate carcinoma.
    Scobioala S; Kittel C; Elsayad K; Kroeger K; Oertel M; Samhouri L; Haverkamp U; Eich HT
    Radiat Oncol; 2019 Aug; 14(1):143. PubMed ID: 31399115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interfraction Anatomical Variability Can Lead to Significantly Increased Rectal Dose for Patients Undergoing Stereotactic Body Radiotherapy for Prostate Cancer.
    Wahl M; Descovich M; Shugard E; Pinnaduwage D; Sudhyadhom A; Chang A; Roach M; Gottschalk A; Chen J
    Technol Cancer Res Treat; 2017 Apr; 16(2):178-187. PubMed ID: 27199276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dosimetric comparison of tomotherapy and volumetric modulated arc therapy in the treatment of high-risk prostate cancer with pelvic nodal radiation therapy.
    Pasquier D; Cavillon F; Lacornerie T; Touzeau C; Tresch E; Lartigau E
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):549-54. PubMed ID: 22677369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of aSi-kVCBCT for Volume Assessment and Dose Estimation: An Offline Adaptive Study for Prostate Radiotherapy.
    Gandhi A; Vellaiyan S; Subramanian S; Swamy ST; Subramanian K; Ayyalusamy A
    Asian Pac J Cancer Prev; 2019 Jan; 20(1):229-234. PubMed ID: 30678437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric and volumetric changes in the rectum and bladder in patients receiving CBCT-guided prostate IMRT: analysis based on daily CBCT dose calculation.
    Pearson D; Gill SK; Campbell N; Reddy K
    J Appl Clin Med Phys; 2016 Nov; 17(6):107-117. PubMed ID: 27929486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.
    Murthy V; Shukla P; Adurkar P; Master Z; Mahantshetty U; Shrivastava S
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):119-24. PubMed ID: 22300567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT.
    Malone S; Croke J; Roustan-Delatour N; Belanger E; Avruch L; Malone C; Morash C; Kayser C; Underhill K; Li Y; Malone K; Nyiri B; Spaans J
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):725-32. PubMed ID: 22444999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric and volumetric effects in clinical target volume and organs at risk during postprostatectomy radiotherapy.
    Gawish A; Chughtai AA; Eble MJ
    Strahlenther Onkol; 2019 May; 195(5):383-392. PubMed ID: 30334066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maximizing rectal dose sparing with hydrogel: A retrospective planning study.
    Paetkau O; Gagne IM; Pai HH; Lam J; Goulart J; Alexander A
    J Appl Clin Med Phys; 2019 Apr; 20(4):91-98. PubMed ID: 30889318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a rectal spacer with prostate SABR-first UK experience.
    King RB; Osman SO; Fairmichael C; Irvine DM; Lyons CA; Ravi A; O'Sullivan JM; Hounsell AR; Mitchell DM; McGarry CK; Jain S
    Br J Radiol; 2018 Feb; 91(1083):20170672. PubMed ID: 29182384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
    Kishan AU; Park SJ; King CR; Roberts K; Kupelian PA; Steinberg ML; Kamrava M
    Br J Radiol; 2015; 88(1056):20150658. PubMed ID: 26463234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric impact of rectum and bladder anatomy and intrafractional prostate motion on hypofractionated prostate radiation therapy.
    Roch M; Zapatero A; Castro P; Hernández D; Chevalier M; García-Vicente F
    Clin Transl Oncol; 2021 Nov; 23(11):2293-2301. PubMed ID: 33913091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.